Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04513145 · ClinicalTrials.gov registry record · Phase 2

Adductor Canal Block

A Phase 2 study of Osteoarthritis and Total Knee Replacement, sponsored by OrthoCarolina Research Institute.

Active
Registry status
Phase 2
Development phase
130
Enrollment target
1
Study location

NCT04513145: Active Phase 2 study of Osteoarthritis and Total Knee Replacement, sponsored by OrthoCarolina Research Institute.

NCT04513145 is a Phase 2 study of Osteoarthritis and Total Knee Replacement that is active but no longer recruiting, run by OrthoCarolina Research Institute. The registered enrollment target is 130 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04513145, a Phase 2 study of Osteoarthritis and Total Knee Replacement, is active but no longer recruiting, sponsored by OrthoCarolina Research Institute.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The investigators aim to investigate whether the addition of a surgeon-administered adductor canal blockade to a multimodal periarticular injection cocktail provides additional pain relief for patients undergoing total knee arthroplasty. This study will help identify the effectiveness of surgeon-administered adductor canal blockade in perioperative pain control for patients undergoing total knee arthroplasty

Primary Outcome

Pain will be measured before discharge on postoperative day 1 on a scale of 0 (no pain) - 10 (worst pain)

Interventions

  • PROCEDURE Total Knee Arthroplasty
  • DRUG Ropivacaine injection
  • DRUG Saline Injection

Study Locations (1)

North Carolina

  • OrthoCarolina Research Institute, OrthoCarolina, P.A. - Charlotte

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2020-10-09
Est. Completion 2025-12-31
Phase Phase 2
OrthoCarolina Research Institute

28 total trials

What the registry record for NCT04513145 still lists

NCT04513145 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which Total Knee Arthroplasty is the first listed.

NCT04513145 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT04513145 about?

NCT04513145 is a clinical study titled "Adductor Canal Block". The investigators aim to investigate whether the addition of a surgeon-administered adductor canal blockade to a multimodal periarticular injection cocktail provides additional pain relief for patients undergoing total knee arthroplasty. This study will help identify the effectiveness of surgeon-adm...

What is the current status of trial NCT04513145?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 130 participants. The study started on 2020-10-09. Estimated completion is 2025-12-31.

What conditions does trial NCT04513145 study?

This clinical trial studies the following conditions: Osteoarthritis, Total Knee Replacement.

What interventions are being tested in trial NCT04513145?

The interventions under investigation include: Total Knee Arthroplasty (PROCEDURE), Ropivacaine injection (DRUG), Saline Injection (DRUG).

Who is sponsoring clinical trial NCT04513145?

This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04513145 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04513145's enrollment target sits among peer trials

130 79th of 135 higher than 57 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04513145, the US trial registry maintained by the National Library of Medicine. NCT04513145 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.